Abnormal Volume Juniper Pharmaceuticals, Inc.’s (JNP)

Juniper Pharmaceuticals, Inc.’s (JNP) witnessed no change 0.00% in recent trading period with closing price of $ 8.20. The company’s last traded volume of 0.05 million shares was up it’s an average volume of 0.11 million shares.

In the trailing 12 months period, return on assets ratio of the Company was -2.70% and return on equity ratio was -4.00% while its return on investment ratio was 40.40%.

The stock as of last trading session moved 110.31% up from its 52 week low and was -38.11% behind its 52 week high.

The stock’s price switched up -10.58% 20-Days Simple Moving Average, dropped -16.06% from 50-Days Simple Moving Average and rose 28.78% from 200 Days Simple Moving Average. The company price to cash ratio of 4.35.

Juniper Pharmaceuticals, Inc.’s (JNP) stock price

In the profitability analysis, net profit margin of the firm was recorded at -3.20% and operating profit margin was calculated at -7.70% while gross profit margin was measured as 42.10%. Beta factor, which measures the riskiness of the security, was registered at 0.52.

U.S stock market on Wednesday

The Dow Jones Industrial Average on Wednesday finished near the lows of the session following an update from the Federal Reserve that signaled that the central bank was taking notice of an uptick in inflation but aren’t likely to increase its rate increases to more than three the market is expecting for 2018. The Dow DJIA, -0.72% fell 174 points, or 0.7%, at 23,924, registering a fourth straight decline for the blue-chip gauge. The S&P 500 index SPX, -0.72% fell by 0.7% at 2,636, while the Nasdaq Composite Index COMP, -0.42% which had been the outperformer among the main equity benchmarks due to better-than-expected results from Apple Inc. AAPL, -0.52% slipped by 0.4% at 7,100. The Fed on Wednesday kept a key U.S. interest rate steady at a range of 1.50% to 1.75%, saying that while inflation has moved higher, it’s likely to run near the central bank’s 2% target in the coming months. According to Market Watch.

Earnings per share formula

EPS = (Net Income – Dividends on Preferred Stock) / Average Outstanding Shares

EPS growth for this year is 246.30% and EPS growth for next year is expected to reach at -62.29%. EPS growth in past five years was 16.10% . Sales growth past 5 years was measured at 14.10% .The Company has 11.34 million shares outstanding and 10.37 million shares were floated in market.

The short ratio in the company’s stock is documented at 1.36 and the short float is around of 1.41%. The average true range of the stock is observed at 0.68 and the relative strength index of the stock is recorded at 41.27.

Analyst recommendation for this stock stands at 2.00. The P/E ratio was recorded at 4.36.The volatility in the previous week has experienced by 5.80% and observed of 6.22% in the previous month.41.00% ownership is held by institutional investors while insiders hold ownership of 3.20%.

JNP stock news

In the liquidity ratio analysis; quick ratio for most recent quarter was 1.80 while current ratio for time period was 2.20. In most recent quarter, LT Debt/Equity ratio was listed at 0.08 and Total Debt/Equity ratio was noted at 0.09.

Performance history:

Looking about the past performance history, the company jumped 3.14% in past week and declined -22.64% in one month. During the past three month period the stock surged 3.80% and increased 70.83% in past six month. During the twelve month it added 76.34% and year to date performance of 69.07%.

Healthcare Reporter

I am Rafael  Schneider and i focus on breaking news stories and ensuring we (“Get Stocks News”) offer timely reporting on some of the most recent stories released through market wires about “Healthcare” Sector companies. I have formerly spent over 5 years as a trader in U.S. Stock Market and is now semi-stepped down. I work on a full time basis for getstocksnews.com specializing in quicker moving active shares with a short term view on investment opportunities and trends.

Address:  1772 Jones Street, Arlington, TX 76011

Phone:  (+1)-817-528-3744

Email:  Rafael@getstocksnews.com

Leave a Reply

Your email address will not be published. Required fields are marked *